THE Therapeutic Goods Administration (TGA) is seeking comments from interested stakeholders on proposed amendments to the Poisons Standard referred by the delegate for scheduling advice to the Advisory Committee on Chemicals and Medicines Scheduling.
Upscheduling of Pentobarbital (Pentobarbitone) injection is proposed from S4 to S8 because of reported misuse, especially its involvement in suicides.
Cannabis scheduling and label changes are being considered with relation to cannabinoid levels in hemp seed oil.
Another consideration relates to an amendment of epidermal growth factor's S7 entry.
Submission relating to the proposals should reach the TGA by 20 Oct - see www.tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Sep 16
